This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Sprinter Legend Balloon Catheter

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Medtronic Vascular
ClinicalTrials.gov Identifier:
NCT00961311
First received: July 14, 2009
Last updated: October 21, 2011
Last verified: October 2011
Results First Received: January 27, 2011  
Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Condition: Coronary Artery Disease
Interventions: Procedure: Percutaneous Coronary Intervention
Device: Sprinter Legend 1.25mm Balloon Catheter

  Participant Flow


  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Balloon Angioplasty All patients with systematic ischemic heart disease with stenotic lesions that are amenable to percutaneous coronary treatment. Study participants were treated with the Sprinter Legend 1.25mm angioplasty balloon.

Baseline Measures
   Balloon Angioplasty 
Overall Participants Analyzed 
[Units: Participants]
 51 
Age 
[Units: Years]
Mean (Standard Deviation)
 67  (10) 
Gender 
[Units: Participants]
 
Female   5 
Male   46 
Region of Enrollment 
[Units: Participants]
 
United States   51 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Procedural Success   [ Time Frame: 1-3 days ]

2.  Secondary:   Major Adverse Cardic Events (MACE)   [ Time Frame: 1-3 days ]

3.  Secondary:   Vessel Perforation (Clinical)   [ Time Frame: 1-3 days ]

4.  Secondary:   Device Success   [ Time Frame: 1-3 days ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information